Annexin Pharmaceuticals AB
Clinical-stage biotech developing a cell-protecting biologic for RVO and oncology.
ANNX | ST
Overview
Corporate Details
- ISIN(s):
- SE0009664154
- LEI:
- 5493000JP703HGPJEX27
- Country:
- Sweden
- Address:
- KAMMAKARGATAN 48, 111 60 Stockholm
- Website:
- https://annexinpharma.com/
- Sector:
- Manufacturing
Description
Annexin Pharmaceuticals AB is a clinical-stage biotechnology company focused on developing ANXV, a recombinant human protein, Annexin A5. This first-in-class biologic acts as a cell protector and immune modulator by targeting and binding to phosphatidylserine (PS), a lipid exposed on the surface of stressed, damaged, or cancerous cells. This mechanism forms a protective shield, counteracting cellular stress, reducing inflammation, and helping damaged cells recover. The company's lead program is evaluating ANXV in a Phase 2 clinical study for the treatment of Retinal Vein Occlusion (RVO), a common cause of vision impairment. ANXV is also being investigated for its potential in oncology, where it may enable the immune system to attack cancer cells. The drug candidate's fundamental mode of action provides broad therapeutic potential across various diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Annexin Pharmaceuticals AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Annexin Pharmaceuticals AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Annexin Pharmaceuticals AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
